International HIFU, a subsidiary of SonaCare Medical, LLC., supports physicians in the delivery of care with the Sonablate® 500. International HIFU's North American Treatment Centers enable U.S. patients and physicians to gain access to HIFU technology for prostate cancer in locations where it is available for use, including Nassau, Bahamas; Cancun and Puerto Vallarta, Mexico; Bermuda; and Montreal and Winnipeg, Canada. The Sonablate® 500 is approved for use in more than 30 countries outside the U.S. for the treatment of prostate cancer. The Sonablate® 500 can be found in additional areas such as Argentina, Australia, Brazil, China, Dominican Republic, Europe (Austria, France, Germany, Hungary, Italy, Romania, Russia, Spain, United Kingdom) India, Iran, Japan and Vietnam.